Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Huang, MD, PhD
Motif BioSciences
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
56 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bulgaria
Sofia, Sofia-Grad, Bulgaria
- Bulgaria
Sofia, Bulgaria
- Chile
Temuco, Chile
- Colombia
Barranquilla, Colombia
- Germany
Cologne, Northwest, Germany
- Germany
Dessau, Germany
- Germany
Mainz, Germany
- Germany
Münster, Germany
- Latvia
Daugavpils, Latvia
- Latvia
Liepāja, Latvia
- Latvia
Riga, Latvia
- Latvia
Riga, Latvia
- Latvia
Rēzekne, Latvia
- Peru
Cerro de Pasco, LIM, Peru
- Peru
Cusco, Peru
- Peru
Ica, Peru
- Peru
La Libertad, Peru
- Peru
Lima, Peru
- Peru
Lima, Peru
- Peru
Lima, Peru
- Peru
Piura, Peru
- Peru
San Borja, Peru
- Peru
San Juán de Miraflores, Peru
- Poland
Bydgoszcz, Poland
- Poland
Olsztyn, Poland
- Poland
Warsaw, Poland
- Poland
Wroclaw, Poland
- Puerto Rico
Ponce, Puerto Rico
- Puerto Rico
Rio Grande, Puerto Rico
- Ukraine
Cherkasy, Ukraine
- Ukraine
Ivano-Frankivsk, Ukraine
- Ukraine
Ivano-Frankivsk, Ukraine
- Ukraine
Kharkiv, Ukraine
- Ukraine
Kharkiv, Ukraine
- Ukraine
Kiev, Ukraine
- Ukraine
Odesa, Ukraine
- Ukraine
Odesa, Ukraine
- Ukraine
Zaporizhzhya, Ukraine
- Ukraine
Zaporizhzhya, Ukraine
- Ukraine
Zaporizhzhya, Ukraine
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Nov 2015
- Primary completion
- 30 Jan 2017
- Completion
- 30 Jan 2017
- Last update posted
- 19 Jun 2018
- Registered enrollment
- 600
- Registry id
- NCT02600611
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.